THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- RACDResearch Alliance Corp IVPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−0.4%13G ↗
- SMMTSummit Therapeutics IncOther events.−29.7%8-K 8.01 ↗
- YUMCYum China Holdings, IncA director bought $248K of stock.$248K−2.1%Form 4 ↗
- OSCROscar Health, IncOfficer or director change.−20.4%8-K 5.02 ↗
- HSICHenry Schein IncRegulation FD disclosure.−3.1%8-K 7.01 ↗
- ECORelectroCore, IncA director bought $54K of stock.$54K−15.8%Form 4 ↗
- RZLTRezolute, IncMaterial agreement and Regulation FD disclosure.+7.3%8-K 1.01 ↗
- MSCSTUDIO CITY INTERNATIONAL HOLDINGS LtdA director bought $31K of stock.$31K+12.8%Form 4 ↗
- BHVNBiohaven LtdRegulation FD disclosure.−10.3%8-K 7.01 ↗
- ACRSAclaris Therapeutics, IncRegulation FD disclosure and other events.−12.2%8-K 7.01 ↗
- HOWLWerewolf Therapeutics, IncPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−3.4%13G ↗
- XXII22nd Century Group, IncResults of operations.−56.3%8-K 2.02 ↗
- DOXAmdocs LTDA director bought $104K of stock.$104K−8.1%Form 4 ↗
- IORIncome Opportunity Realty Investors IncShareholder vote.0.0%8-K 5.07 ↗
- KALAKALA BIO, IncOther events.+1846.0%8-K 8.01 ↗
- CUECue Biopharma, IncPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−74.3%13G ↗
- MEDSDataMeds AI, IncMaterial agreement.+80.1%8-K 1.01 ↗
- SLXNSilexion Therapeutics CorpResults of operations.−33.8%8-K 2.02 ↗
- NXGLNexgel, IncThe Interim CEO bought $733K of stock.$733K−19.6%Form 4 ↗
- NXGLNexgel, IncA director bought $25K of stock.$25K−19.6%Form 4 ↗
- PUSAPowerus CorpOther events.−16.0%8-K 8.01 ↗
- ATCHAtlasClear Holdings, IncResults of operations.−16.4%8-K 2.02 ↗
- HYACHaymaker Acquisition Corp VPassive stake of 5% or more (13G), filed by Haymaker Sponsor V.13G ↗
- VIRVir Biotechnology, IncMaterial agreement and other events.
Vir Biotechnology Announces Proposed Public Offering
−15.8%8-K 1.01 ↗ - STIMNeuronetics, IncJorey Chernett, a 10% owner, bought $80K of stock.$80K−10.1%Form 4 ↗
- XGNExagen IncJorey Chernett, a 10% owner, sold $746K of stock.$746K−12.6%Form 4 ↗
- VANIVivani Medical, IncThe Chief Business Officer bought $20K of stock.$20K+12.9%Form 4 ↗
- FICOFair Isaac CorpOne officer sold $15.0M of stock in two filings, $14.8M of it under plans set in advance.$15.0M−3.6%
- FICOFair Isaac CorpThe President and CEO sold $184K of stock.$184K−3.6%Form 4 ↗
- FICOFair Isaac CorpThe President and CEO sold $14.8M of stock under a 10b5-1 plan.$14.8M−3.6%Form 4 ↗
- STWDStarwood Property Trust, IncA director bought $2.0M of stock.$2.0M−4.5%Form 4 ↗
- STWDStarwood Property Trust, IncThe CEO, Chairman of the Board bought $14.7M of stock.$14.7M−4.5%Form 4 ↗
- BHAIUBHAV Acquisition Corp IIBHAV Partners II, a 10% owner, bought 5,098 shares.Form 4 ↗
- NTRANatera, IncA director sold $479K of stock under a 10b5-1 plan.$479K−14.3%Form 4 ↗
- LFSTLifeStance Health Group, IncAn officer sold $40.9M of stock under a 10b5-1 plan.$40.9M−1.8%Form 4 ↗
- ALMRAlamar Biosciences, IncQiming GP VIII, a 10% owner, sold $2.9M of stock.$2.9M−14.1%Form 4 ↗
- HEHawaiian Electric Industries IncRegulation FD disclosure.−8.0%8-K 7.01 ↗
- CRMDCorMedix IncRegulation FD disclosure.+13.1%8-K 7.01 ↗
- LYVLive Nation Entertainment, IncThe EVP, M&A and Strategic Finance sold $2.0M of stock.$2.0M−2.0%Form 4 ↗
- LYVLive Nation Entertainment, IncThe President & CFO sold $16.7M of stock.$16.7M−2.0%Form 4 ↗
- FRPHFRP Holdings, IncThe CEO bought $930 of stock.$930−5.1%Form 4 ↗
- MAXMediaAlpha, IncThe Chief Technology Officer sold $176K of stock under a 10b5-1 plan.$176K−8.2%Form 4 ↗
- INDIindie Semiconductor, IncA director bought $299K of stock.$299K−27.6%Form 4 ↗
- ORKAOruka Therapeutics, Inc2 insiders sold $2.9M of stock, all under plans set in advance.$2.9M−9.1%
- ORKAOruka Therapeutics, IncThe Senior Vice President, Finance sold $1.0M of stock under a 10b5-1 plan.$1.0M−9.1%Form 4 ↗
- ORKAOruka Therapeutics, IncA director sold $1.9M of stock under a 10b5-1 plan.$1.9M−9.1%Form 4 ↗
- TOMZTOMI Environmental Solutions, IncResults of operations.
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results Company Delivers 24% Q3 Revenue Growth and Returns to Positive Operating Income
−15.8%8-K 2.02 ↗ - CRWDCrowdStrike Holdings, IncOne officer sold $6.8M of stock in two filings, all under plans set in advance.$6.8M+1.2%
- CRWDCrowdStrike Holdings, IncThe President and CEO sold $582K of stock under a 10b5-1 plan.$582K+1.2%Form 4 ↗
- CRWDCrowdStrike Holdings, IncThe President and CEO sold $6.3M of stock under a 10b5-1 plan.$6.3M+1.2%Form 4 ↗
- PLTRPalantir Technologies IncAn officer sold $64.9M of stock under a 10b5-1 plan.$64.9M−14.6%Form 4 ↗
- THCTenet Healthcare CorpA director sold $293K of stock.$293K−8.0%Form 4 ↗
- ADPTAdaptive Biotechnologies CorpThe President and COO sold $1.0M of stock under a 10b5-1 plan.$1.0M−3.8%Form 4 ↗